BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9266623)

  • 1. Availability of iron and degree of inflammation modifies the response to recombinant human erythropoietin when treating anemia of chronic disease in patients with rheumatoid arthritis.
    Nordström D; Lindroth Y; Marsal L; Hafström I; Henrich C; Rantapää-Dahlqvist S; Engström-Laurent A; Fyhrquist F; Friman C
    Rheumatol Int; 1997; 17(2):67-73. PubMed ID: 9266623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
    Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
    Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
    Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.
    Dusenbery KE; McGuire WA; Holt PJ; Carson LF; Fowler JM; Twiggs LB; Potish RA
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1079-84. PubMed ID: 8083076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of erythropoietin-resistant anaemia with desferrioxamine in patients on haemofiltration.
    Goch J; Birgegård G; Danielson BG; Wikström B
    Eur J Haematol; 1995 Aug; 55(2):73-7. PubMed ID: 7628592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
    Sweeney PJ; Nicolae D; Ignacio L; Chen L; Roach M; Wara W; Marcus KC; Vijayakumar S
    Br J Cancer; 1998 Jun; 77(11):1996-2002. PubMed ID: 9667681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
    Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C
    Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin.
    Labonia WD
    Am J Kidney Dis; 1995 Nov; 26(5):757-64. PubMed ID: 7485128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin.
    Major A; Mathez-Loic F; Rohling R; Gautschi K; Brugnara C
    Br J Haematol; 1997 Aug; 98(2):292-4. PubMed ID: 9266922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
    Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
    Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation.
    Pettersson T; Rosenlöf K; Friman C; Mickos A; Teppo AM; Fyhrquist F
    Scand J Rheumatol; 1993; 22(4):188-93. PubMed ID: 8356412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients.
    Sundal E; Kaeser U
    Nephrol Dial Transplant; 1989; 4(11):979-87. PubMed ID: 2516891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin and the anaemia of chronic disease.
    Krantz SB
    Nephrol Dial Transplant; 1995; 10 Suppl 2():10-7. PubMed ID: 7644100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of iron in hemodialysis patients treated with erythropoietin: evidence for the inhibitory role of aluminum.
    Donnelly SM; Ali MA; Churchill DN
    Am J Kidney Dis; 1990 Nov; 16(5):447-51. PubMed ID: 2239935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis.
    Vreugdenhil G; Manger B; Nieuwenhuizen C; Feelders RA; van Eijk HG; Swaak AJ
    Ann Hematol; 1992 Dec; 65(6):265-8. PubMed ID: 1457588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.
    Stone WJ; Graber SE; Krantz SB; Dessypris EN; O'Neil VL; Olsen NJ; Pincus TP
    Am J Med Sci; 1988 Sep; 296(3):171-9. PubMed ID: 3177433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.